\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes HealthThe ISIDORe consortium has recently launched a call for proposals to support scientists with an interest in SARS-CoV-2 and COVID-19. This open call is a cascade funding initiative offering third parties the opportunity to make use of transnational access to ISIDORe services free of charge. Applications will be evaluated, selected and implemented on a rolling basis as long as funding remains available.
You can request transnational access to ISIDORe for research focused on: Surveillance & epidemic risk management; Understanding SARS-COV-2 & COVID-19; Diagnostics; Therapeutics; Vaccines; Social sciences & epidemiology
More information on the specific topics and how to apply on the project website.
The Horizon Europe funded project ISIDORe assembles the largest and most diverse research and service-providing instrument to study infectious diseases in Europe, with expertise from structural biology to clinical trials. By giving scientists access to the whole extent of its facilities, cutting-edge services and advanced equipment, the project aims to accelerate the generation of new knowledge and intervention tools in order to enhance Europe’s capacity for controlling (re)emerging and epidemic infectious diseases.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
